Endovia Health Sciences delays quarterly report amid staffing, resource constraints
EDVA•
EDVA•Endovia Health Sciences delayed its Form 10-Q for the quarter ended September 30, 2026, citing limited personnel and resources. It expects to file within five calendar days of the deadline; nine-month revenue fell below $10,000 from approximately $50,000 a year earlier.
Endovia Health Sciences delayed its Form 10-Q for the quarter ended September 30, 2026, citing limited personnel and resources. The company expects to file within five calendar days of the prescribed deadline as it continues preparing and reviewing its financial statements.
An ongoing accounting review and auditor procedures prevent the company from reasonably estimating anticipated changes in operating results. Nine-month revenue fell below $10,000 from approximately $50,000 a year earlier, reflecting discontinued beverage sales and a business-model shift.